EBV

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

Golidocitinib Combined With Selinexor for CAEBVD

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

Belatacept 3 Month Post Transplant Conversion Study

Response Prediction in EBV-HLH Using Metabonomics Analysis

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

CNTRP POSITIVE Study

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial

Cytotoxic T Cells to Prevent Virus Infections

Plasma EBV DNA Monitoring in Post-treatment NPC Patients

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma

Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis

Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation